Respiratory viral infections often present with similar symptoms — fever, cough, congestion, sore throat — making clinical differentiation difficult. This multiplex molecular panel rapidly identifies SARS-CoV-2 (COVID-19), influenza A, influenza B, and respiratory syncytial virus (RSV) from a single specimen, allowing targeted treatment and infection control.
This test is widely used during respiratory virus season in clinics, emergency departments, and urgent care to guide treatment decisions including antiviral selection (such as oseltamivir for influenza or Paxlovid for COVID-19) and patient isolation. Sample type is a nasopharyngeal or nasal swab.
We are CLIA certified, the highest level of Medical industry compliance and standards.
Book an appointment